Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Although physicians do not have legitimate authority over patients, professional associations may have such authority over physicians, even nonmembers.
AMA J Ethics. 2017;19(2):207-213. doi:
10.1001/journalofethics.2017.19.2.sect1-1702.
Pharmacologic interventions might help physicians overcome cognitive deficits resulting from loss of sleep while on call or help them retain more details about the patients under their care.
Medical specialty boards improve the quality and safety of health care, but they can overreach, and their board members express disapproval of board action by petition and through legal action.
AMA J Ethics. 2015;17(3):193-198. doi:
10.1001/journalofethics.2015.17.3.spec1-1503.
Fabian von Knoch, MD, Anthony Marchie, MD, MPhil, and Henrik Malchau, MD, PhD
An argument that national joint registries have improved outcomes for arthroplasty patients because they track device performance, reduce revision surgeries, and promote evidence-based surgery.